Evidence map›Paper›PMID 35055994›Full record

ArticlePathogens (Basel, Switzerland)2021

GOLT1B Activation in Hepatitis C Virus-Infected Hepatocytes Links ER Trafficking and Viral Replication.

Jacqueline Butterworth, Damien Gregoire, Marion Peter, Armando Andres Roca Suarez, Guillaume Desandré, Yannick Simonin, Alessia Virzì, Amal Zine El Aabidine, Marine Guivarch, Jean-Christophe Andrau and 4 more

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jacqueline ButterworthInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.
Damien GregoireInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.ORCID 0000-0002-1105-8115
Marion PeterInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.
Armando Andres Roca SuarezInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 67000 Strasbourg, France.
Guillaume DesandréInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.
Yannick SimoninInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.ORCID 0000-0002-3475-1369
Alessia VirzìInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 67000 Strasbourg, France.ORCID 0000-0002-0348-9601
Amal Zine El AabidineInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.
Marine GuivarchInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 67000 Strasbourg, France.
Jean-Christophe AndrauInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.
Edouard BertrandInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.
Eric AssenatInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.
Joachim LupbergerInserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 67000 Strasbourg, France.ORCID 0000-0003-3996-3907
Urszula HibnerInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, 34293 Montpellier, France.
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales 2015-2 15437Agence Nationale de Recherches sur le Sida et les Hépatites Virales 2016-1 4446Fondation pour la Recherche Médicale FDT201805005763HTE Program from ITMO Cancer Aviesan HTE201610
6 · The paper itself

Abstract

Chronic hepatitis C carries a high risk of development of hepatocellular carcinoma (HCC), triggered by both direct and indirect effects of the virus. We examined cell-autonomous alterations in gene expression profiles associated with hepatitis C viral presence. Highly sensitive single molecule fluorescent in situ hybridization applied to frozen tissue sections of a hepatitis C patient allowed the delineation of clusters of infected hepatocytes. Laser microdissection followed by RNAseq analysis of hepatitis C virus (HCV)-positive and -negative regions from the tumoral and non-tumoral tissues from the same patient revealed HCV-related deregulation of expression of genes in the tumor and in the non-tumoral tissue. However, there was little overlap between both gene sets. Our interest in alterations that increase the probability of tumorigenesis prompted the examination of genes whose expression was increased by the virus in the non-transformed cells and whose level remained high in the tumor. This strategy led to the identification of a novel HCV target gene: GOLT1B, which encodes a protein involved in ER-Golgi trafficking. We further show that GOLT1B expression is induced during the unfolded protein response, that its presence is essential for efficient viral replication, and that its expression is correlated with poor outcome in HCC.

Indexed as

hepatitis Chepatocellular carcinomasmiFISHtranscriptomic profiling

Identifiers

PMID35055994
PMCPMC8781247
OpenAlexW4206480834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.